Light Therapy Market Size, Share & Growth Graph By 2034

(MENAFN- Straits Research) Light Therapy Market Size

The light therapy market size was valued at USD 1.03 billion in 2025 and is projected to grow from USD 1.07 billion in 2026 to USD 15.14 billion by 2034 at a CAGR of 4.37% during the forecast period (2026-2034), as per Straits Research Analysis.

The light therapy market is growing steadily as demand increases for non-invasive treatment of conditions such as seasonal affective disorder, acne, psoriasis, and sleep disorders. Rising awareness of mental health encourages adoption in both clinical and home settings. In 2025, Philips expanded its SmartSleep portfolio with app-connected wake-up lights that help regulate circadian rhythms, showing strong consumer-focused innovation. At the same time, LumeBox gained popularity with portable devices designed for SAD and jet lag, reflecting growing demand for convenient solutions. Improvements in LED-based multi-wavelength technology increase treatment effectiveness and flexibility. Collaborations between device manufacturers and dermatology clinics support product validation and trust. Expanding e-commerce platforms boost global accessibility. However, high device costs and limited reimbursement policies continue to restrict wider adoption in developing regions, highlighting the need for affordable and clinically proven light therapy solutions.

Key Market Insights

North America dominated the light therapy market with the largest share of 43.20% in 2025. The Asia Pacific is expected to be the fastest-growing region in the market during the forecast period, registering a CAGR of 5.88%. Based on product, the hand-held devices segment is expected to register a growth rate of 4.85% during the forecast period. Based on light type, the red segment is projected to grow at a CAGR of 5.12% during the forecast period. Based on application, the skin disorders segment dominated the market, accounting for 31.42% revenue share in 2025. Based on end user, the dermatology clinics segment dominated the market with a share of 40.73%in 2025. The US light therapy market size was valued at USD 401.51 million in 2025 and is projected to reach USD 418.33 million in 2026.

Market Summary

Market Metric	Details & Data (2025-2034)
2025 Market Valuation	USD 1.03 billion
Estimated 2026 Value	USD 1.07 billion
Projected 2034 Value	USD 15.14 billion
CAGR (2026-2034)	4.37%
Dominant Region	North America
Fastest Growing Region	Asia Pacific
Key Market Players	Carex Health Brands, Revian Inc., Lucimed SA, PhotoMedex Inc., BioPhotas Inc.

Emerging Trends in Light Therapy Market Shift toward Wearable Circadian-optimized Light Systems

The market is shifting toward wearable, circadian-optimized devices that dynamically adjust light intensity and wavelength based on user behavior and sleep cycles. Companies such as Koninklijke Philips N.V. are advancing app-linked light wearables that sync with biometric data from smartwatches and sleep trackers. These systems use real-time feedback to regulate melatonin suppression and improve sleep quality. Integration with AI-driven sleep analytics platforms enables personalized therapy schedules, increasing treatment adherence. This trend is expanding adoption among shift workers, frequent travelers, and individuals with chronic sleep disorders, driving strong consumer demand in home-care segments.

Shift toward Multi-Spectrum Dermatology-Grade Photobiomodulation Platforms

A key market trend is the use of multi-spectrum photobiomodulation systems that combine red, blue, and near-infrared light for targeted skin and tissue repair. The Kleresca system in dermatology clinics applies fluorescent light energy to treat acne and reduce inflammation while supporting skin renewal. These platforms are increasingly used in clinical dermatology settings for acne vulgaris and rosacea management. They rely on controlled wavelength delivery and timed exposure protocols to improve collagen stimulation and healing outcomes. Integration with clinic-based treatment plans enhances consistency and patient monitoring, supporting wider acceptance in medical skincare and non-invasive aesthetic procedures.

Market Drivers Expansion of Chronotherapy-based Light Exposure Protocols and Rising Prevalence of Skin Disorders Drive Market

The increasing use of chronotherapy-based light exposure in sleep medicine clinics is driving growth in the market. Hospitals apply timed bright-light sessions to treat circadian rhythm disorders such as delayed sleep phase and shift work disorder. Clinical adoption is supported by evidence-based guidance from the National Institutes of Health, which recognizes bright light therapy as an effective approach to regulate circadian rhythms and melatonin timing. For example, sleep clinics use structured morning blue-enriched light exposure to improve sleep onset and reset body clocks. Integration with polysomnography improves treatment precision and outcomes.

The rising prevalence of skin disorders that require non-invasive dermatology treatments is driving demand for light therapy products. Skin conditions such as acne and atopic dermatitis. remain highly common globally, with acne alone affecting about 9.4% of the world population, making it one of the most widespread dermatological diseases in 2025. Large European population studies report that acne affects 5.4% and eczema about 5.5% of adults, showing a consistently high disease burden across regions. These growing cases increase demand for blue and red light therapy devices used in acne reduction, inflammation control, and skin healing. Rising patient preference for drug-free and home-based dermatology care further supports adoption of such solutions in clinical and consumer markets.

Market Restraints Low Insurance Reimbursement Coverage and Limited Standardization in Regulatory Approval Restrain Market Growth

The limited insurance reimbursement for consumer and home-use devices for conditions such as seasonal affective disorder, acne, and sleep disorders restrains market growth. Most payers classify light therapy lamps, LED masks, and circadian lighting systems as wellness or lifestyle products rather than essential medical treatments. For example, home SAD light boxes cost between USD 100 and 500 and are rarely covered by public or private insurance plans, even when clinically recommended. This out-of-pocket burden reduces adoption in price-sensitive populations and slows penetration in developing healthcare systems despite proven clinical benefits.

Lack of uniform regulatory pathways for photobiomodulation and LED-based devices impacts product commercialization. Regulatory bodies such as the US Food and Drug Administration classify many light therapy products differently depending on their claims, from general wellness to medical devices. For example, some LED acne masks receive clearance for“non-invasive treatment of mild acne,” while similar devices with minor specification changes enter the market without equivalent clinical validation requirements. This inconsistency creates confusion for manufacturers and clinicians, slows product approval timelines, and limits trust in consumer-grade devices, restraining broader market adoption.

Market Opportunities Integration of Light Therapy into Digital Sleep Coaching and Clinical Photobiomodulation in Sports Rehabilitation Therapy Offer Growth Opportunities for Market Players

The integration of light therapy devices into digital sleep coaching platforms offers new growth avenues for existing market players. Wearable devices and smart apps now track sleep cycles, heart rate, and circadian rhythm patterns to personalize light exposure timing. For example, the Philips SmartSleep Wake-up Light uses sleep insights to adjust morning light intensity, helping users wake more naturally and improve sleep quality. Integration with platforms like Apple Health, linked to sleep tracking, also enables automatic light scheduling. This combination improves user adherence, enhances treatment outcomes, and supports expansion of home-based sleep wellness solutions globally.

Expansion of clinical photobiomodulation in sports medicine and rehabilitation therapy offers new opportunities for the market. Red and near-infrared light is increasingly used to reduce muscle inflammation, improve tissue repair, and speed recovery after injuries. For example, professional sports physiotherapy centers use Joovv systems to support muscle recovery and joint healing in athletes after intense training or injury. These devices are also combined with physiotherapy and cryotherapy for better outcomes. Growing demand from sports teams, fitness centers, and rehabilitation clinics increases adoption and creates new clinical and commercial growth opportunities.

Regional Insights North America: Market Leadership through Adoption in Corporate Wellness Programs and High Prevalence of Seasonal Affective Disorder

The North America light therapy market accounted for a revenue share of 43.20% in 2025 due to the high adoption of circadian lighting in corporate wellness programs, where tech companies and hospitals use tunable LED systems to reduce fatigue and improve productivity. For example, in 2025, workplaces in the US increasingly installed smart daylight-mimicking lighting systems integrated with IoT sensors to regulate employee alertness during winter months. Strong clinical use of FDA-cleared dermatology light devices in cosmetic clinics for acne and anti-aging treatments, widely adopted in urban US centers. These factors collectively drive regional market growth.

The US market is growing due to the rapid adoption of VA and military rehabilitation programs using red and near-infrared photobiomodulation for pain management, wound healing, and traumatic brain injury recovery in veterans. Another key factor is integration of light therapy in telehealth sleep clinics, where US-based platforms prescribe circadian light devices alongside virtual cognitive behavioral therapy for insomnia. In addition, strong demand from high-altitude and aviation professionals, such as pilots and flight crews, drives use of portable devices to manage jet lag and circadian misalignment during frequent cross-time-zone travel.

Canada's market benefits from the high prevalence of seasonal affective disorder, especially in northern provinces like Manitoba, Yukon, and Newfoundland, where long winters reduce sunlight exposure for several months. Clinical surveys show SAD affects about 2-3% of Canadians, and seasonal low mood affects up to 15% of the population during winter, increasing demand for light therapy lamps. Another key factor is circadian disruption among shift workers in healthcare and mining sectors, where light therapy is used to regulate sleep cycles and reduce fatigue.

Asia Pacific: Fastest Growth Driven by Rising Prevalence of Sleep Disorders and Rapid Integration of LED Phototherapy

The Asia Pacific light therapy market is expected to register the fastest growth with a CAGR of 5.88% during the forecast period, due to rising urban sleep disorders caused by high population density and long working hours in Japan and South Korea, where shift work culture is highly common. For example, large Japanese corporations like office-based IT and manufacturing firms increasingly install circadian lighting systems in workplaces to reduce employee fatigue and improve alertness during night shifts. Another key driver is the rapid expansion of dermatology clinics in China and India using LED-based therapy for acne and pigmentation treatment, supported by high skin disorder prevalence and growing aesthetic awareness.

The Chinese market is growing due to rapid integration of LED phototherapy into high-throughput medical aesthetic chains that operate standardized treatment protocols for acne, pigmentation, and post-laser recovery across tier-1 cities such as Shanghai, Beijing, and Shenzhen. Increasing adoption in ophthalmology clinics for myopia-related eye strain management among students, where low-level red light devices are used as supportive therapy alongside vision correction programs. In addition, China's strong domestic manufacturing ecosystem in Shenzhen enables fast commercialization of low-cost wearable light masks, accelerating product adoption through e-commerce.

The India light therapy market is driven by the rising burden of chronic pigmentary skin disorders, such as psoriasis and vitiligo, which require repeated non-invasive phototherapy sessions. Clinical dermatology studies in India report psoriasis prevalence around 8% and vitiligo near 1% of dermatology patients in hospital-based settings, showing a consistent treatment need in outpatient care networks. The growing availability of portable home-use phototherapy devices, allowing patients in tier-2 cities to continue maintenance treatment outside hospitals, improves accessibility and supports market growth in this country.

By Product

The light boxes segment dominates the product market, accounting for 27.06% in 2025 due to strong clinical use in treating seasonal affective disorder and circadian rhythm disorders with standardized 10,000-lux exposure therapy. Low cost and easy accessibility compared to wearable devices, making it widely adopted in home care settings. Strong hospital and telehealth prescription support increases patient trust and repeat usage across North America and Europe.

The handheld devices segment is expected to grow at a CAGR of 4.85% during the forecast period. This growth is accelerated by rising demand for portable dermatology solutions, especially for acne and pigmentation management in urban populations. Increasing adoption among sports physiotherapy users for localized pain and inflammation relief using red-light handheld applicators collectively drives growth in the handheld devices segment.

By Light Type

The blue segment dominated the market with a share of 33.61% in 2025, owing to its strong bactericidal action against Cutibacterium acne, which makes it highly effective for acne and oily skin conditions. It is preferred because it works at shallow skin depth, targeting surface-level infections without damaging deeper tissues, ensuring safe, non-invasive treatment. Short treatment time and compatibility with handheld devices make it convenient for daily skincare routines.

The red segment is expected to grow at a CAGR of 5.12% during the forecast period because of expanding use in musculoskeletal and deep-tissue therapy applications beyond dermatology. It is increasingly adopted in physiotherapy and sports recovery clinics because it helps reduce muscle soreness, joint stiffness, and inflammation after injury. Increasing integration in wellness and biohacking routines, where consumers use red light beds for sleep improvement and energy regulation, also boosts market adoption.

By Application

The skin disorders segment dominated the market, accounting for 31.42% revenue share in 2025. This dominance can be attributed to the standardized use of narrowband UV and LED-based protocols in dermatology clinics, where controlled dosing improves treatment consistency for long-term skin management. For example, hospital dermatology units routinely use phototherapy cabins for psoriasis plaque clearance and vitiligo repigmentation as part of long-term care programs. Rising preference for non-drug-based dermatology care supports the adoption of light therapy devices.

The depression & sleep-cycle disorders segment is projected to grow at a CAGR of 4.97% during the forecast period, as these conditions show rising global prevalence and strong clinical linkage with circadian disruption. Insomnia alone affects up to 10% of the global population, making it one of the most common sleep disorders, driving light therapy demand. Depression is also frequently associated with sleep and circadian rhythm disruption, where irregular light exposure worsens symptoms and delays recovery.

By End User

The dermatology clinics segment dominated the market, accounting for 40.73% revenue share in 2025. This growth is supported by high patient inflow, procedural combination therapy, advanced phototherapy infrastructure, post-laser recovery usage, and standardized treatment protocols for acne, psoriasis, and pigmentation disorders. Clinics also benefit from repeat treatment cycles and strong adoption of FDA-cleared light devices, making them the primary end-use setting for controlled and supervised light therapy applications globally.

The home care settings segment is projected to grow at a CAGR of 5.07% during the forecast period due to the adoption of self-managed dermatology and wellness devices in North America, where high out-of-pocket spending encourages at-home acne and seasonal affective disorder treatment using light boxes and LED masks. In Europe, a rising aging population and preference for non-clinical chronic skin management support home phototherapy use for conditions like psoriasis and eczema, especially in countries like Germany and the UK.

Competitive Landscape

The light therapy market is moderately consolidated, with global companies and niche brands competing actively across clinical and consumer segments. Leading players such as Koninklijke Philips N.V., Beurer GmbH, and Verilux Inc. offer diverse product portfolios, strong brand presence, and wide distribution networks. Specialized firms like BioPhotas Inc. and Northern Light Technologies focus on targeted applications such as skincare and seasonal affective disorder. Competition is driven by product innovation, affordability, and multi-functional devices, while partnerships and product launches continue to support global market growth and adoption across regions.

List of Key and Emerging Players in Light Therapy Market Carex Health Brands Revian Inc. Lucimed SA PhotoMedex Inc. BioPhotas Inc. Northern Light Technologies Verilux Inc. Beurer GmbH Koninklijke Philips N.V. Samarit Medical AG TheraLight LLC Johnson & Johnson Services Inc. Lumenis Ltd. Mito Red Light RedDot LED Zepter International Natus Medical Alcon PureluxTech Joovv Inc. Omnilux CurrentBody Foreo Zerigo Health Dermalux LED Merican Optoelectronic EZ-Therapylight Recent Developments

In April 2026, PureluxTech expanded its FDA-cleared red light therapy device portfolio, targeting OEM/ODM partnerships with global wellness brands and accelerating the commercialization of photobiomodulation devices. In September 2025, Alcon completed the acquisition of LumiThera, integrating its Valeda light therapy device for dry age-related macular degeneration into its ophthalmology portfolio.

Report Scope

Report Metric	Details
Market Size in 2025	USD 1.03 billion
Market Size in 2026	USD 1.07 billion
Market Size in 2034	USD 15.14 billion
CAGR	4.37% (2026-2034)
Base Year for Estimation	2025
Historical Data	2022-2024
Forecast Period	2026-2034
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered	By Product, By Light Type, By Application, By End User
Geographies Covered	North America, Europe, APAC, Middle East and Africa, LATAM
Countries Covered	US, Canada, UK, Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia

Download Free Sample Report to Get Detailed Insights.

Light Therapy Market Segments By Product

Light Boxes Floor & Desk Lamps Light Visors Dawn Simulators Light Therapy Bulbs Handheld Devices Other Products

By Light Type

White Blue Red Others

By Application

Vitamin D Deficiency Seasonal Affective Disorder (SAD) Depression & Sleep-cycle Disorders Skin Disorders
Psoriasis Vitiligo Eczema Other Disorders
Other Application

By End User

Hospitals Dermatology Clinics Home Care Settings Other End Users

By Region

North America Europe APAC Middle East and Africa LATAM

MENAFN22042026004597010906ID1111014450